Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05698095 · ClinicalTrials.gov registry record · Phase 1
Pharmacokinetics, Safety, and Tolerability of Intramuscular 5-MeO-DMT in Healthy Volunteers
A Phase 1 study, sponsored by Usona Institute.
- Completed
- Registry status
- Phase 1
- Development phase
- 54
- Enrollment target
NCT05698095 is a Phase 1 study that has completed, run by Usona Institute. The registered enrollment target is 54 participants.
The verdict
NCT05698095, a Phase 1 study, has completed, sponsored by Usona Institute.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 54 participants
- Enrollment target
Study Summary
The primary objective of the study is to assess the pharmacokinetics, safety, and tolerability of a single-dose and multiple-doses of 5-MeO-DMT administered by intramuscular (IM) injections in healthy subjects.
Interventions
- DRUG Placebo
- DRUG 5-methoxy-N,N-dimethyltryptamine succinate salt
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 54 participants |
| Start Date | 2022-12-27 |
| Est. Completion | 2023-09-07 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05698095
The ClinicalTrials.gov registry entry for NCT05698095 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 54 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Usona Institute, which has 5 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Placebo is the first listed.
NCT05698095 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT05698095 about?
NCT05698095 is a clinical study titled "Pharmacokinetics, Safety, and Tolerability of Intramuscular 5-MeO-DMT in Healthy Volunteers". The primary objective of the study is to assess the pharmacokinetics, safety, and tolerability of a single-dose and multiple-doses of 5-MeO-DMT administered by intramuscular (IM) injections in healthy subjects.
What is the current status of trial NCT05698095?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 54 participants. The study started on 2022-12-27. Estimated completion is 2023-09-07.
What interventions are being tested in trial NCT05698095?
The interventions under investigation include: Placebo (DRUG), 5-methoxy-N,N-dimethyltryptamine succinate salt (DRUG).
Who is sponsoring clinical trial NCT05698095?
This trial is sponsored by Usona Institute, which has 5 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.